Average Co-Inventor Count = 7.72
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (20 from 3,923 patents)
20 patents:
1. 12441733 - Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitors
2. 11702409 - Pyrazolyl derivatives useful as anti-cancer agents
3. 11613543 - Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors
4. 11541056 - 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives
5. 11203595 - Aza-indazole compounds for use in tendon and/or ligament injuries
6. 10766894 - Aza-indazole compounds for use in tendon and/or ligament injuries
7. 10683287 - Heterocyclic derivatives and their use in the treatment of neurological disorders
8. 10301296 - Heterocyclic derivatives and their use in the treatment of neurological disorders
9. 10112907 - Substituted indazoles for treating tendon and/or ligament injuries
10. 10035794 - Heterocyclic derivatives and their use in the treatment of neurological disorders
11. 9550758 - Heterocyclic derivatives and their use in the treatment of neurological disorders
12. 9284284 - Oxazine derivatives and their use in the treatment of disease
13. 9163011 - Oxazine derivatives and their use in the treatment of disease
14. 8865712 - Heterocyclic derivatives and their use in the treatment of neurological disorders
15. 8637508 - Heterocyclic derivatives and their use in the treatment of neurological disorders